A group of 8 plaintiffs have filed suit against against GlaxoSmithKline in Texas over alleged damage caused by Avandia. According to court filings, the plaintiffs allege that the use of Avandia caused them to suffer various heart and cardiovascular problems.
The plaintiffs are seeking a full refund for the Type II diabetes medication, compensation for physical and mental pain, physical impairment, future medical expenses, and other damages.
The lawsuit alleges Avandia is a defective product due to patients being placed a too high a risk for suffering heart attacks or other heart related injuries. The lawsuit goes further to accuse GlaxoSmithKline of fraud, negligence, gross negligence, unjust enrichment and violation of the Deceptive Trade Practices Act.